Preliminary agenda is live: Explore the 2025 STAT Summit lineup

From CRISPR breakthroughs to biotech's future, see the early lineup — with more announcements ahead.

Log In    2025 STAT Summit Preliminary Agenda is Live! Get a first look at the speakers and topics shaping the 2025 STAT summit. VIEW THE AGENDA SUMMIT NEWS | STAT SUMMIT See who's joining us on stage this October The preliminary agenda is now live, and the 2025 STAT Summit is beginning to take shape. Here are a few highlights from the 2025 agenda: A Milestone for Gene Editing — KJ Muldoon's family and the researchers who used CRISPR to correct his rare genetic disease will share what they accomplished and what it could mean for medicine. Biotech Faces FDA Uncertainty — A panel of industry veterans will discuss the challenges of navigating shifting U.S. drug regulation and what companies can do to prepare. The Future of Biotech Financing — Noubar Afeyan, Arie Belldegrun, and other company-creators will join STAT's Adam Feuerstein and Allison DeAngelis to debate how innovation will be funded in the years ahead. And that's just the beginning — leaders from Eli Lilly, GSK, Isomorphic Labs, and many more will also take the stage. Explore the growing lineup. REGISTER NOW Featured Speakers Ben Wolf, M.D., Ph.D. Chief Medical Officer, Isomorphic Labs Emma Walmsley Chief Executive Officer, GSK Joe Kennedy III Former U.S. Congressman, MA-4; President, Citizens Energy; Founder, Groundwork Project Alondra Nelson, Ph.D. Former Deputy Assistant to President Joe Biden & Director, White House Office of Science and Technology Policy Daniel Skovronsky, M.D., Ph.D. Chief Scientific Officer and President of Lilly Research Laboratories and Lilly Immunology Michelle Xia, Ph.D. President and CEO, Akeso Biopharma STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us